M.D., University of Washington, 1978.
Ph.D., University of Washington, 1974.
Dr. Burke is an expert in the implications and appropriate use of genetic information in clinical and public health practice. Her research addresses the bioethical and health policy implications of genetic technology.
American Public Health Association
American Society of Human Genetics
Association for Prevention Teaching and Research
Society of General Internal Medicine
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.. American journal of human genetics.. 2016.
Patient safety in genomic medicine: an exploratory study.. Genetics in medicine : official journal of the American College of Medical Genetics.. 2016.
Community crystal gazing.. Nature biotechnology. 34(3):276-83.. 2016.
The Deceptive Appeal of Direct-to-Consumer Genetics.. Annals of internal medicine. 164(8):564-5.. 2016.
Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide.. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics. 43(3):486-501.. 2015.
Patients' Choices for Return of Exome Sequencing Results to Relatives in the Event of Their Death.. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics. 43(3):476-85.. 2015.
Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015.
Actionable exomic incidental findings in 6503 participants: challenges of variant classification.. Genome research. 25(3):305-15.. 2015.
The FDA and genomic tests--getting regulation right.. The New England journal of medicine. 372(23):2258-64.. 2015.
Response to Strong.. Genetics in medicine : official journal of the American College of Medical Genetics. 17(8):682-3.. 2015.
Community dissemination and genetic research: Moving beyond results reporting.. American journal of medical genetics. Part A.. 2015.
Design, implementation, and first-year outcomes of a value-based drug formulary.. Journal of managed care & specialty pharmacy. 21(4):269-75.. 2015.
Response to phillips et Al.. Genetics in medicine : official journal of the American College of Medical Genetics. 17(4):315.. 2015.
Closing the gap between knowledge and clinical application: challenges for genomic translation.. PLoS genetics. 11(2):e1004978.. 2015.
Looking for Trouble and Finding It.. The American journal of bioethics : AJOB. 15(7):15-7.. 2015.
Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas.. Pharmacogenomics. 16(3):227-37.. 2015.
WHAT DNA CAN AND CANNOT SAY: PERSPECTIVES OF IMMIGRANT FAMILIES ABOUT THE USE OF GENETIC TESTING IN IMMIGRATION.. Stanford law & policy review. 26:597-638.. 2015.
Effects of web-based intervention on risk reduction behaviors in melanoma survivors.. Journal of cancer survivorship : research and practice.. 2014.
The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.. Genetics in medicine : official journal of the American College of Medical Genetics.. 2014.
Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between.. American journal of human genetics.. 2014.
Exploring pathways to trust: a tribal perspective on data sharing.. Genetics in medicine : official journal of the American College of Medical Genetics.. 2014.
Native Hawaiian Views on Biobanking.. Journal of cancer education : the official journal of the American Association for Cancer Education.. 2014.
Return of results: Ethical and legal distinctions between research and clinical care.. American journal of medical genetics. Part C, Seminars in medical genetics. 166(1):105-11.. 2014.
Clinical decisions. Screening an asymptomatic person for genetic risk.. The New England journal of medicine. 370(25):2442-5.. 2014.